The study by Scripps Research Institute scientists focuses on the role of this new tumour suppressor in lymphoma induced by Myc oncoproteins (the cancer-promoting products of Myc oncogenes). This circuit is apparently operational in all human tumours with MYC involvement, which is more than half of all human tumour types, the study has found.
"This opens a new therapeutic avenue to exploit for cancers with Myc involvement
